News

June 5th, 2025

inSoma Accepted to MedTech Innovator 2025

We’re proud to share that inSoma Bio, Inc. has been selected to join the 2025 MedTech Innovator cohort, the world’s largest accelerator for medical device companies.

This recognition highlights the exceptional work of our team and underscores the potential of our technology to drive meaningful impact in healthcare. As part of a highly competitive program with an acceptance rate under 4%, we’re excited to join a global community of innovators shaping the future of medicine.

Stay tuned as we continue advancing regenerative solutions that transform patient outcomes.

September 30th, 2024

Co-Founder Dr. Scott Hollenbeck, MD named President of ASPS

Scott Hollenbeck, MD, co-founder of inSoma Bio, has been named president of the American Society of Plastic Surgeons (ASPS), the world’s largest organization of board-certified plastic surgeons, representing more than 11,000 members globally. Dr. Hollenbeck took office on September 29, 2024, during the Society’s annual meeting in San Diego. As president, Dr. Hollenbeck aims to highlight the fundamental value of plastic surgery in the U.S. healthcare system, advocating for enhanced patient safety, ensuring access to services, and promoting the importance of consulting board-certified surgeons for cosmetic or reconstructive procedures. A leader in academic medicine and innovation, we are incredibly proud to work alongside him and his vision for a better future for patients

Read whole article
June 20th, 2024

Dr. Heather Brennan Joins inSoma Board of Directors

inSoma is pleased to announce the addition of Heather Brennan, Ph.D., to its Board of Directors. Dr. Brennan is passionate about women’s health and has 20 years of medical device and regenerative medicine experience. She currently serves as CEO of PracticeWise, a behavioral health company. Prior to PracticeWise, Dr. Brennan was General Manager, Global Markets at Establishment Labs where she managed a $165M global breast reconstruction and aesthetics business. She also previously served as Vice President and General Manager of MTF Biologics’ Plastic and Reconstructive Surgery Franchise, where she developed and led the strategic direction of the business, growing revenue by 500% and solidifying a leadership spot for the company in post-mastectomy breast reconstruction. Dr. Brennan received her Ph.D. in biomedical engineering from Rutgers University and her bachelor’s degree in mechanical engineering from Lehigh University.